TSLA
Tesla
-- 424.770 NVDA
NVIDIA
-- 139.310 PLTR
Palantir
-- 72.510 RGTI
Rigetti Computing
-- 7.3800 SMCI
Super Micro Computer
-- 38.290 
NEWS
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
• Company has received supportive feedback from the FDA regarding a registrational clinical trial design
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
• Company has received supportive feedback from the FDA regarding a registrational clinical trial design
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
102057627 : Rises and falls.